| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 31 Oct 2026 | 24 Oct 2026 |
| Nukleus Office Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 inter alia to consider and approve We hereby inform you that a meeting of the Board of Directors of the Company will be held on Saturday October 31 2026 inter alia to consider and approve the following: 1. The Un-audited Financial Results (subject to Limited Review) of the Company for the half year ended September 30 2026; 2. Alteration of the Memorandum of Association (MOA) of the Company in respect of the Objects Clause (Clause III); 3. Increase in the Authorised Share Capital of the Company and consequential alteration of the Capital Clause (Clause V) of the MOA; 4. The Postal Ballot Notice for seeking the approval of the Members on the matters at items 2 and 3 above appointment of the Scrutinizer(s) and fixing of the cut-off date; and 5. Any other matter with the permission of the Chair. Board Meeting Outcome for As Enclosed Herewith. (As per BSE announcement dated on : 31.10.2026) | ||
| Board Meeting | 29 Aug 2026 | 24 Aug 2026 |
| Nukleus Office Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2026 inter alia to consider and approve 1. To consider formulate and approve the Employee Stock Option Plan / Scheme 2026 NUKLEUS OFFICE SOLUTIONS LIMITED ESOP Scheme-I 2026 subject to the approval of shareholders and relevant regulatory authorities. 2. To approve the draft notice of the General Meeting to seek necessary shareholder approvals. As enclosed herewith. (As per BSE Announcement dated on: 29.08.2026) | ||
| Board Meeting | 16 May 2026 | 10 May 2026 |
| Nukleus Office Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2026 inter alia to consider and approve The Audited Financial Results for the Half-Yearly and Year ended March 31 2026. Audited Financial Results for the Half-Year and Year ended 31 March 2026, along with Audit Report, approved and taken on record at the meeting of the Board of Directors held today i.e. on 16th, May 2026. (As Per BSE Announcement Dated on 16.05.2026) | ||
| Board Meeting | 11 Nov 2025 | 6 Nov 2025 |
| Nukleus Office Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 inter alia to consider and approve Board Meeting Intimation for To Consider And Approve The Un-Audited Limited Reviewed Financial Statements (Standalone) For The Half-Year Ended 30th September 2025. Outcome of the Board Meeting (As per BSE Announcement dated on: 11.11.2025) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.